Christopher J. Williams - 31 Dec 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 15:22:30 UTC
Previous filing
02 Nov 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +75 +0.7% $0.000000 10,765 10 Nov 2021 Common Stock 75 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +919 +8.5% $0.000000 11,684 31 Dec 2021 Common Stock 919 Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +184 +1.6% $0.000000 11,868 31 Dec 2021 Common Stock 184 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.